Methods for drug safety signal detection using routinely collected observational electronic health care data: A systematic review

被引:11
|
作者
Coste, Astrid [1 ]
Wong, Angel [1 ]
Bokern, Marleen [1 ]
Bate, Andrew [1 ,2 ]
Douglas, Ian J. [1 ]
机构
[1] LSHTM, Dept Noncommunicable Dis Epidemiol, London, England
[2] Global Safety, Brentford, England
关键词
drug safety surveillance; pharmacoepidemiology; pharmacovigilance; real world data; signal detection; systematic review; CONTROLLED CASE SERIES; SPONTANEOUS REPORTING DATABASE; SEQUENCE SYMMETRY ANALYSIS; LONGITUDINAL DATABASES; EMPIRICAL-ASSESSMENT; RISK IDENTIFICATION; ADVERSE EVENTS; SURVEILLANCE; CLAIMS; RECORDS;
D O I
10.1002/pds.5548
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose Signal detection is a crucial step in the discovery of post-marketing adverse drug reactions. There is a growing interest in using routinely collected data to complement established spontaneous report analyses. This work aims to systematically review the methods for drug safety signal detection using routinely collected healthcare data and their performance, both in general and for specific types of drugs and outcomes. Methods We conducted a systematic review following the PRISMA guidelines, and registered a protocol in PROSPERO. MEDLINE, EMBASE, PubMed, Web of Science, Scopus, and the Cochrane Library were searched until July 13, 2021. Results The review included 101 articles, among which there were 39 methodological works, 25 performance assessment papers, and 24 observational studies. Methods included adaptations from those used with spontaneous reports, traditional epidemiological designs, methods specific to signal detection with real-world data. More recently, implementations of machine learning have been studied in the literature. Twenty-five studies evaluated method performances, 16 of them using the area under the curve (AUC) for a range of positive and negative controls as their main measure. Despite the likelihood that performance measurement could vary by drug-event pair, only 10 studies reported performance stratified by drugs and outcomes, in a heterogeneous manner. The replicability of the performance assessment results was limited due to lack of transparency in reporting and the lack of a gold standard reference set. Conclusions A variety of methods have been described in the literature for signal detection with routinely collected data. No method showed superior performance in all papers and across all drugs and outcomes, performance assessment and reporting were heterogeneous. However, there is limited evidence that self-controlled designs, high dimensional propensity scores, and machine learning can achieve higher performances than other methods.
引用
收藏
页码:28 / 43
页数:16
相关论文
共 50 条
  • [31] Methods for drug safety signal detection in longitudinal observational databases: LGPS and LEOPARD
    Schuemie, Martijn J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (03) : 292 - 299
  • [32] Using Electronic Healthcare Records for Drug Safety Signal Detection: A Comparative Evaluation of Statistical Methods
    Schuemie, Martijn J.
    Coloma, Preciosa M.
    Straatman, Huub
    Herings, Ron M.
    Trifiro, Gianluca
    Matthews, Justin N.
    Prieto-Merino, David
    Molokhia, Mariam
    Pedersen, Lars
    Gini, Rosa
    Innocenti, Francesco
    Mazzaglia, Giampiero
    Picelli, Gino
    Scotti, Lorenza
    van der Lei, Johan
    Sturkenboom, Miriam C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 342 - 342
  • [33] Measuring continuity of care in general practice: a comparison of two methods using routinely collected data
    Hull, Sally A.
    Williams, Crystal
    Schofield, Peter
    Boomla, Kambiz
    Ashworth, Mark
    BRITISH JOURNAL OF GENERAL PRACTICE, 2022, 72 (724): : E773 - E779
  • [34] Comparison of national mortality data with routinely collected health-care data to measure the occurrence of liver cirrhosis: an observational study
    Ratib, Sonia
    West, Joe
    Fleming, Kate M.
    LANCET, 2014, 384 : 64 - 64
  • [35] Drug-Event Pairs as Indicators for the Detection of Adverse Drug Reactions during Hospitalization in Routinely Collected Electronic Data Sources
    Wermund, Anna Maria
    Haerdtlein, Annette
    Fehrmann, Wolfgang
    Weglage, Clara
    Dreischulte, Tobias
    Jaehde, Ulrich
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025,
  • [36] Indigenous data governance approaches applied in research using routinely collected health data: a scoping review
    Engstrom, Teyl
    Lobo, Elton H.
    Watego, Kristie
    Nelson, Carmel
    Wang, Jinxiang
    Wong, Howard
    Kim, Sungkyung Linda
    Oh, Soo In
    Lawley, Michael
    Gorse, Alain-Dominique
    Ward, James
    Sullivan, Clair
    NPJ DIGITAL MEDICINE, 2024, 7 (01)
  • [37] Indigenous data governance approaches applied in research using routinely collected health data: a scoping review
    Teyl Engstrom
    Elton H. Lobo
    Kristie Watego
    Carmel Nelson
    Jinxiang Wang
    Howard Wong
    Sungkyung Linda Kim
    Soo In Oh
    Michael Lawley
    Alain-Dominique Gorse
    James Ward
    Clair Sullivan
    npj Digital Medicine, 7
  • [38] Allied health in residential aged care: Using routinely collected data to improve funding opportunities
    Meulenbroeks, Isabelle
    Seaman, Karla
    Raban, Magdalena Z.
    Westbrook, Johanna
    AUSTRALASIAN JOURNAL ON AGEING, 2023, 42 (01) : 221 - 224
  • [39] A Reference Standard for Evaluation of Methods for Drug Safety Signal Detection Using Electronic Healthcare Record Databases
    Preciosa M. Coloma
    Paul Avillach
    Francesco Salvo
    Martijn J. Schuemie
    Carmen Ferrajolo
    Antoine Pariente
    Annie Fourrier-Réglat
    Mariam Molokhia
    Vaishali Patadia
    Johan van der Lei
    Miriam Sturkenboom
    Gianluca Trifirò
    Drug Safety, 2013, 36 : 13 - 23
  • [40] A Reference Standard for Evaluation of Methods for Drug Safety Signal Detection Using Electronic Healthcare Record Databases
    Coloma, Preciosa M.
    Avillach, Paul
    Salvo, Francesco
    Schuemie, Martijn J.
    Ferrajolo, Carmen
    Pariente, Antoine
    Fourrier-Reglat, Annie
    Molokhia, Mariam
    Patadia, Vaishali
    van der Lei, Johan
    Sturkenboom, Miriam
    Trifiro, Gianluca
    DRUG SAFETY, 2013, 36 (01) : 13 - 23